Most Recent

image: Week in Review: December 2–6

Week in Review: December 2–6

By | December 6, 2013

Oldest hominin DNA sequence; visualizing dyslexia; testing CRISPR; cancer and autoimmunity

0 Comments

image: A Cancer Culprit in Autoimmunity

A Cancer Culprit in Autoimmunity

By | December 5, 2013

Scientists discover that cancer can drive the autoimmune disorder scleroderma.

0 Comments

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Stinky Cheese

Stinky Cheese

By | December 2, 2013

Researchers collaborate to create fermented food products using microbes harvested from some malodorous parts of the human body.

0 Comments

image: Contributors

Contributors

By | December 1, 2013

Meet some of the people featured in the December 2013 issue of The Scientist.

0 Comments

image: Intracellular Spirals

Intracellular Spirals

By | December 1, 2013

Membrane twists connect stacked endoplasmic reticulum sheets.

0 Comments

image: Mapping NYC's Microbes

Mapping NYC's Microbes

By | December 1, 2013

New York University’s Jane Carlton talks about a project designed to characterize the microbiome of the Big Apple.

0 Comments

image: Metropolome

Metropolome

By | December 1, 2013

Researchers take advantage of rapid and cheap DNA sequencing technologies to map the bacterial microbiome of New York City.

0 Comments

image: Organelle Architecture

Organelle Architecture

By | December 1, 2013

There’s beauty in a cell’s marriage of structure and function.

1 Comment

image: Out, Damned Mycoplasma!

Out, Damned Mycoplasma!

By | December 1, 2013

Pointers for keeping your cell cultures free of mycoplasma contamination

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham